JCHOR

The Journal of Current Hematology & Oncology Research regularly publishes internationally qualified research in hematology and oncology within the current scholarly knowledge. This journal is indexed by indices that are considered international scientific journal indices (DRJI, ESJI, OAJI, etc.). According to the current Associate Professorship criteria, it is within the scope of International Article 1-d. Each article published in this journal corresponds to 5 points.

EndNote Style
Index

Current Issue 2024/2/3

Original Article
The investigation of janus kinase 2 and calreticulin mutations in patients with essential thrombocytosis

Published: 01 Aug 2024

Citation: Ünal S, Yağcı AM. The investigation of janus kinase 2 and calreticulin mutations in patients with essential thrombocytosis. J Curr Hematol Oncol Res. 2024;2(3):54-58.

Original Article
Causes of acquired isolated neutropenia in adulthood: a single center study

Published: 01 Aug 2024

Citation: Keklik M, Mert Yüce M, Akyol G, Mandacı Şanlı N, Çelik S, Eser B. Causes of acquired isolated neutropenia in adulthood: a single center study.J Curr Hematol Oncol Res. 2024;2(3):59-62.

Original Article
Follow-up of patients given isoniazid prophylaxis in multiple myeloma patients underwent autologous stem cell transplantation

Published: 01 Aug 2024

Citation: Akyol G, Keklik M, Kaynar L, Ünal A. Follow-up of patients given isoniazid prophylaxis in multiple myeloma patients underwent autologous stem cell transplantation. J Curr Hematol Oncol Res. 2024;2(3):63-66.

Original Article
The role of therapeutic plasma exchange in the treatment of patients with septic shock- single center experience

Published: 01 Aug 2024

Citation: Çelik S, Erkurt MA, Sarıcı A. The role of therapeutic plasma exchange in the treatment of patients with septic shock- single center experience. J Curr Hematol Oncol Res. 2024;2(3):67-71.

Review
Current status and potential future of PAI-1 inhibitors

Published: 01 Aug 2024

Citation: Tan T, Ağırbaşlı M. Current status and potential future of PAI-1 inhibitors. J Curr Hematol Oncol Res. 2024;2(3): 72-75.

Case Report
A case report of relapsed/refractory primary central nervous system lymphoma

Published: 01 Aug 2024

Citation: Aksöz Z. A case report of relapsed/refractory primary central nervous system lymphoma. J Curr Hematol Oncol Res. 2024; 2(3):76-78.

Most Read Articles

Original Article
ß-catenin expression in myelodysplastic syndromes and myeloproliferative neoplasms in bone marrow, in relation to CD34 and CD117 status

Published: 30 Aug 2023

Citation: Barış Iİ, Büyükbayram H. ß-catenin expression in myelodysplastic syndromes and myeloproliferative neoplasms in bone marrow, in relation to CD34 and CD117 status. J Curr Hematol Oncol Res. 2023;1(3):54-58.

Review
Chronic lymphocytic leukemia

Published: 30 Aug 2023

Citation: Fidan K. Chronic lymphocytic leukemia. J Curr Hematol Oncol Res. 2023;1(3):59-67.

Original Article
Effect of tyrosine kinase inhibitor and conventional chemotherapy on COVID 19 antibody level in hematological patients

Published: 26 Feb 2023

Citation: Kaya A, Berber İ, Kuku İ, et al. Effect of tyrosine kinase inhibitor and conventional chemotherapy on COVID-19 antibody level in hematological patients. J Curr Hematol Oncol Res. 2023; 1(1): 1-4

_Footer